DGX
Quest Diagnostics Inc (DGX)
Healthcare • NYSE • $187.39-1.81%
- Symbol
- DGX
- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Price
- $187.39
- Daily Change
- -1.81%
- Market Cap
- $20.74B
- Trailing P/E
- 20.71
- Forward P/E
- 16.06
- 52W High
- $213.50
- 52W Low
- $164.65
- Analyst Target
- $223.25
- Dividend Yield
- +1.84%
- Beta
- 0.59
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other…
Company websiteResearch DGX on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.